Information  X 
Enter a valid email address

Oilex Ltd (OEX)

  Print      Mail a friend       Annual reports

Monday 30 July, 2018

Oilex Ltd

Tranche 2 Update

RNS Number : 0816W
Oilex Ltd
29 July 2018
 

ASX Announcement

 

30 July 2018

 

ASX: OEX

AIM: OEX

 

Tranche 2 Update

 

Oilex Ltd (the Company) refers to the announcement on 30 April 2018 which advised that the Company had agreed with subscribers to amend the conditions precedent to Tranche 2 of the Placement originally announced by the Company on 12 December 2017. In particular, the date which the conditions precedent was required to be met was extended to 31 July 2018.

While the amendment to the Cambay Production Contract documentation is underway in the ordinary course, the Company does not consider that the conditions precedent for the A$1.75 Tranche 2 are capable of being met by the requisite date per the placing agreement, 31 July 2018. Accordingly, Tranche 2 of the Placement is not anticipated to be completed.

 

 

 

For and on behalf of Oilex Ltd

 

 

 

 

 

 

Mark Bolton

Chief Financial Officer Company Secretary

 

 

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: [email protected]

Tel: +61 8 9485 3200

Australia

AIM Broker

Cornhill Capital Limited

Broker

Daniel Gee

Email: [email protected]

 

Tel: +44 20 3700 2500

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer   

Email: [email protected]

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: [email protected]

[email protected]

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: [email protected]

Tel: +618 6160 4900

Australia

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCVKLBLVDFZBBB

a d v e r t i s e m e n t